Cargando…
Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer’s disease
In Alzheimer’s disease (AD), abnormal sphingolipid metabolism has been reported, although the pathogenic consequences of these changes have not been fully characterized. We show that acid sphingomyelinase (ASM) is increased in fibroblasts, brain, and/or plasma from patients with AD and in AD mice, l...
Autores principales: | Lee, Jong Kil, Jin, Hee Kyung, Park, Min Hee, Kim, Bo-ra, Lee, Phil Hyu, Nakauchi, Hiromitsu, Carter, Janet E., He, Xingxuan, Schuchman, Edward H., Bae, Jae-sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113944/ https://www.ncbi.nlm.nih.gov/pubmed/25049335 http://dx.doi.org/10.1084/jem.20132451 |
Ejemplares similares
-
Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase
por: He, Xingxuan, et al.
Publicado: (2023) -
Recombinant Human Acid Sphingomyelinase as an Adjuvant to Sorafenib Treatment of Experimental Liver Cancer
por: Savić, Radoslav, et al.
Publicado: (2013) -
Autophagic/lysosomal dysfunction in Alzheimer’s disease
por: Orr, Miranda E, et al.
Publicado: (2013) -
Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair
por: Tam, Christina, et al.
Publicado: (2010) -
Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity
por: Park, Na Yeon, et al.
Publicado: (2021)